Drug shortage: Valproate Sodium Injection (VALPROATE SODIUM)
FDA lists 2 presentations as Current. Availability: Unavailable (1), Available (1). Reason: Demand increase for the drug. Companies: Hikma Pharmaceuticals USA, Inc., Fresenius Kabi USA, LLC.
- Published by source
- 2020-12-30
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Hikma Pharmaceuticals USA, Inc.
- Products
- Valproate Sodium Injection VALPROATE SODIUM
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Additional lots will be available. Product will be made available as it is released.
- Next release November 2026. Check wholesalers for inventory.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2020-12-30
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #979 | new | 2026-10-22 | 37a7403c7f20…4e646b | ea37aec3b45a…d6fe12 |
Chain head: #1076 8ad5adc30b9b…88ce20